arrow_back Back to App

Senate Supports Parkinson's Awareness Month and Research Funding

The US Senate officially supports designating April as Parkinson’s Awareness Month to highlight this rapidly growing neurodegenerative disease affecting over a million Americans. The resolution emphasizes the critical need for increased research funding, public education, and community support services for patients and their caregivers. This symbolic action aims to mobilize efforts against a disease projected to cost $80 billion annually by 2037.
Key points
Official designation of April as Parkinson's Awareness Month to boost public understanding and support for those affected.
Senate commitment to continue supporting research aimed at finding better treatments and a cure for Parkinson's disease.
Recognition of patients participating in vital clinical trials and the dedication of caregivers and support organizations.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_SRES_184
Sponsor: Sen. Stabenow, Debbie [D-MI]
Process start date: 2023-04-27
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution expressing support for the designation of April 2023 as "Parkinson's Awareness Month".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_SRES_184.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-04-27.

What are the main provisions?

Key points include:

  • Official designation of April as Parkinson's Awareness Month to boost public understanding and support for those affected.
  • Senate commitment to continue supporting research aimed at finding better treatments and a cure for Parkinson's disease.
  • Recognition of patients participating in vital clinical trials and the dedication of caregivers and support organizations.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Stabenow, Debbie [D-MI].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health